Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Lymphoma

  Free Subscription


1 Am J Surg Pathol
4 Blood
1 Bone Marrow Transplant
1 Br J Dermatol
1 Cancer
2 Haematologica
1 Int J Cancer
3 J Am Acad Dermatol
3 J Clin Oncol
2 Lancet Oncol
3 Leuk Lymphoma
1 Leukemia
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Am J Surg Pathol

  1. SHIMONO J, Miyoshi H, Yoshida N, Kato T, et al
    Analysis of GNA13 Protein in Follicular Lymphoma and its Association With Poor Prognosis.
    Am J Surg Pathol. 2018;42:1466-1471.
    PubMed     Text format     Abstract available


  2. XU-MONETTE ZY, Zhou J, Young KH
    PD-1 expression and clinical PD-1 blockade in B-cell lymphomas.
    Blood. 2018;131:68-83.
    PubMed     Text format     Abstract available

  3. DANIEL R, Chan RY
    Hyperviscosity syndrome in splenic marginal zone lymphoma.
    Blood. 2018;132:1627.
    PubMed     Text format    

    Next-generation therapy for follicular lymphoma.
    Blood. 2018;132:1465-1467.
    PubMed     Text format    

  5. HILL JA, Li D, Hay KA, Green ML, et al
    Infectious complications of CD19-targeted chimeric antigen receptor-modified T-cell immunotherapy.
    Blood. 2018;131:121-130.
    PubMed     Text format     Abstract available

    Bone Marrow Transplant

  6. DOS SANTOS KB, Costa LJM, Bettarello G, da Matta Abreu M, et al
    LEAM versus CBV for conditioning in autologous hematopoietic stem cell transplantation for lymphoma.
    Bone Marrow Transplant. 2018 Oct 3. pii: 10.1038/s41409-018-0349.
    PubMed     Text format    

    Br J Dermatol

  7. DESCHAMPS O, Ram-Wolff C, Beylot-Barry M, Grange F, et al
    Treatment of mycosis fungoides and Sezary syndrome with romidepsin: a series of 32 cases of the French Study Group for Cutaneous Lymphoma.
    Br J Dermatol. 2018 Oct 9. doi: 10.1111/bjd.17269.
    PubMed     Text format     Abstract available


  8. KENZIK KM, Mehta A, Richman JS, Kilgore M, et al
    Congestive heart failure in older adults diagnosed with follicular lymphoma: a population-based study.
    Cancer. 2018 Oct 10. doi: 10.1002/cncr.31695.
    PubMed     Text format     Abstract available


  9. EVRARD SM, Pericart S, Grand D, Amara N, et al
    Targeted next generation sequencing reveals high mutation frequency of CREBBP, BCL2 and KMT2D in high-grade B-cell lymphoma with MYC and BCL2 and /or BCL6 rearrangements.
    Haematologica. 2018 Oct 11. pii: haematol.2018.198572.
    PubMed     Text format    

  10. CASAGRANDE N, Borghese C, Visser L, Mongiat M, et al
    CCR5 antagonism by maraviroc inhibits Hodgkin lymphoma microenvironment interactions and xenograft growth.
    Haematologica. 2018 Oct 11. pii: haematol.2018.196725.
    PubMed     Text format     Abstract available

    Int J Cancer

  11. SUBRAMANIAN K, Dierckx T, Khouri R, Menezes SM, et al
    Decreased RORC expression and downstream signaling in HTLV-1-associated Adult T-cell Lymphoma/Leukemia uncovers an antiproliferative IL17 link: a potential target for immunotherapy?
    Int J Cancer. 2018 Oct 10. doi: 10.1002/ijc.31922.
    PubMed     Text format     Abstract available

    J Am Acad Dermatol

  12. LEE MH, Choi ME, Won CH, Chang SE, et al
    Comparative Clinicopathological Analysis of Cutaneous Peripheral T-cell lymphoma, Not Otherwise Specified, According to Primary Tumor Site.
    J Am Acad Dermatol. 2018 Oct 5. pii: S0190-9622(18)32663.
    PubMed     Text format    

  13. WARREN S, Kheterpal M, Myskowski PL, Moskowitz A, et al
    Unrelated immunodeficiency states may impact outcomes and immune checkpoint molecule expression in patients with mycosis fungoides: A clinicopathologic case-control study.
    J Am Acad Dermatol. 2017 Nov 10. pii: S0190-9622(17)32339.
    PubMed     Text format     Abstract available

  14. NA SJ, Kang MJ, Yu DS, Han KD, et al
    Cancer risk in patients with Behcet disease: A nationwide population-based dynamic cohort study from Korea.
    J Am Acad Dermatol. 2018;78:464-470.
    PubMed     Text format     Abstract available

    J Clin Oncol

  15. HUNTINGTON SF, von Keudell G, Davidoff AJ, Gross CP, et al
    Cost-Effectiveness Analysis of Brentuximab Vedotin With Chemotherapy in Newly Diagnosed Stage III and IV Hodgkin Lymphoma.
    J Clin Oncol. 2018 Oct 4:JCO1800122. doi: 10.1200/JCO.18.00122.
    PubMed     Text format     Abstract available

  16. LOCKMER S, Ostenstad B, Hagberg H, Holte H, et al
    Chemotherapy-Free Initial Treatment of Advanced Indolent Lymphoma Has Durable Effect With Low Toxicity: Results From Two Nordic Lymphoma Group Trials With More Than 10 Years of Follow-Up.
    J Clin Oncol. 2018 Oct 4:JCO1800262. doi: 10.1200/JCO.18.00262.
    PubMed     Text format     Abstract available

  17. ALDERUCCIO JP, Zhao W, Desai A, Gallastegui N, et al
    Risk Factors for Transformation to Higher-Grade Lymphoma and Its Impact on Survival in a Large Cohort of Patients With Marginal Zone Lymphoma From a Single Institution.
    J Clin Oncol. 2018 Oct 12:JCO1800138. doi: 10.1200/JCO.18.00138.
    PubMed     Text format     Abstract available

    Lancet Oncol

  18. TROTMAN J, Barrington SF, Belada D, Meignan M, et al
    Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial.
    Lancet Oncol. 2018 Oct 8. pii: S1470-2045(18)30618.
    PubMed     Text format     Abstract available

    Personalised approach in follicular lymphoma.
    Lancet Oncol. 2018 Oct 8. pii: S1470-2045(18)30688.
    PubMed     Text format    

    Leuk Lymphoma

  20. FARRUGGIA P, Puccio G, Locatelli F, Vetro M, et al
    Classical pediatric Hodgkin lymphoma in very young patients: the Italian experience.
    Leuk Lymphoma. 2018 Oct 10:1-7. doi: 10.1080/10428194.2018.1493732.
    PubMed     Text format     Abstract available

  21. REIMAN T, Savage KJ, Crump M, Cheung MC, et al
    A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 studydagger.
    Leuk Lymphoma. 2018 Oct 10:1-8. doi: 10.1080/10428194.2018.1515937.
    PubMed     Text format     Abstract available

  22. LE CLEF Q, Ortega-Sanchez G, Dirnhofer S, Tzankov A, et al
    T-lymphoblastic lymphoma after previous thymoma: how NGS helps establishing the diagnosis and procures new insights.
    Leuk Lymphoma. 2018 Oct 10:1-4. doi: 10.1080/10428194.2018.1520993.
    PubMed     Text format    


  23. HOUOT R, Cartron G, Bijou F, de Guibert S, et al
    Obinutuzumab plus Lenalidomide (GALEN) for the treatment of relapse/refractory aggressive lymphoma: a phase II LYSA study.
    Leukemia. 2018 Oct 5. pii: 10.1038/s41375-018-0282.
    PubMed     Text format    

    PLoS One

  24. BRESIN A, Ragone G, Cristofoletti C, Arcelli D, et al
    T Cell Leukemia/Lymphoma 1A is essential for mouse epidermal keratinocytes proliferation promoted by insulin-like growth factor 1.
    PLoS One. 2018;13:e0204775.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.